Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of HIKAL.. For more details, see the HIKAL. quarterly results and HIKAL. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.7 |
No. of shares | m | 123.30 |
1 Week | % | 4.6 |
1 Month | % | 13.6 |
1 Year | % | 7.1 |
52 week H/L | Rs | 331.1/258.6 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
HIKAL. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 265 | 187 | 204 | 742 | 456 | |
Low | Rs | 135 | 57 | 67 | 145 | 216 | |
Sales per share (Unadj.) | Rs | 128.9 | 122.2 | 139.5 | 157.6 | 164.1 | |
Earnings per share (Unadj.) | Rs | 8.4 | 6.8 | 10.8 | 13.0 | 6.4 | |
Diluted earnings per share | Rs | 8.4 | 6.8 | 10.8 | 13.0 | 6.4 | |
Cash flow per share (Unadj.) | Rs | 15.9 | 13.5 | 17.7 | 20.8 | 15.2 | |
Dividends per share (Unadj.) | Rs | 1.20 | 1.20 | 2.00 | 1.60 | 1.20 | |
Adj. dividends per share | Rs | 1.20 | 1.20 | 2.00 | 1.60 | 1.20 | |
Avg Dividend yield | % | 0.6 | 1.0 | 1.5 | 0.4 | 0.4 | |
Book value per share (Unadj.) | Rs | 61.3 | 66.2 | 75.7 | 86.6 | 91.9 | |
Adj. book value per share | Rs | 61.3 | 66.2 | 75.7 | 86.6 | 91.9 | |
Shares outstanding (eoy) | m | 123.30 | 123.30 | 123.30 | 123.30 | 123.30 | |
Price / Sales ratio | x | 1.6 | 1.0 | 1.0 | 2.8 | 2.0 | |
Avg P/E ratio | x | 23.9 | 17.8 | 12.6 | 34.1 | 52.8 | |
P/CF ratio (eoy) | x | 12.6 | 9.0 | 7.7 | 21.3 | 22.1 | |
Price / Book Value ratio | x | 3.3 | 1.8 | 1.8 | 5.1 | 3.7 | |
Dividend payout | % | 14.4 | 17.5 | 18.5 | 12.3 | 18.9 | |
Avg Mkt Cap | Rs m | 24,682 | 15,052 | 16,738 | 54,672 | 41,420 | |
Total wages/salary | Rs m | 1,357 | 1,566 | 1,643 | 2,034 | 2,224 |
HIKAL. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 15,896 | 15,073 | 17,204 | 19,427 | 20,230 | |
Other income | Rs m | 23 | 37 | 50 | 49 | 54 | |
Total revenues | Rs m | 15,919 | 15,110 | 17,254 | 19,476 | 20,284 | |
Gross profit | Rs m | 2,981 | 2,578 | 3,229 | 3,406 | 2,571 | |
Depreciation | Rs m | 929 | 825 | 852 | 957 | 1,090 | |
Interest | Rs m | 584 | 524 | 362 | 312 | 481 | |
Profit before tax | Rs m | 1,491 | 1,266 | 2,064 | 2,186 | 1,054 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 460 | 421 | 733 | 581 | 270 | |
Profit after tax | Rs m | 1,031 | 844 | 1,331 | 1,605 | 784 | |
Gross profit margin | % | 18.8 | 17.1 | 18.8 | 17.5 | 12.7 | |
Effective tax rate | % | 30.9 | 33.3 | 35.5 | 26.6 | 25.6 | |
Net profit margin | % | 6.5 | 5.6 | 7.7 | 8.3 | 3.9 |
HIKAL. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 8,865 | 8,312 | 9,251 | 10,232 | 9,683 | |
Current liabilities | Rs m | 6,590 | 6,528 | 7,033 | 8,281 | 6,908 | |
Net working cap to sales | % | 14.3 | 11.8 | 12.9 | 10.0 | 13.7 | |
Current ratio | x | 1.3 | 1.3 | 1.3 | 1.2 | 1.4 | |
Inventory Days | Days | 22 | 37 | 26 | 26 | 26 | |
Debtors Days | Days | 80 | 82 | 103 | 82 | 80 | |
Net fixed assets | Rs m | 8,882 | 10,482 | 10,906 | 13,048 | 15,024 | |
Share capital | Rs m | 247 | 247 | 247 | 247 | 247 | |
"Free" reserves | Rs m | 7,316 | 7,918 | 9,087 | 10,433 | 11,088 | |
Net worth | Rs m | 7,562 | 8,165 | 9,334 | 10,680 | 11,335 | |
Long term debt | Rs m | 2,978 | 3,034 | 2,629 | 2,867 | 4,899 | |
Total assets | Rs m | 17,747 | 18,794 | 20,157 | 23,280 | 24,707 | |
Interest coverage | x | 3.6 | 3.4 | 6.7 | 8.0 | 3.2 | |
Debt to equity ratio | x | 0.4 | 0.4 | 0.3 | 0.3 | 0.4 | |
Sales to assets ratio | x | 0.9 | 0.8 | 0.9 | 0.8 | 0.8 | |
Return on assets | % | 9.1 | 7.3 | 8.4 | 8.2 | 5.1 | |
Return on equity | % | 13.6 | 10.3 | 14.3 | 15.0 | 6.9 | |
Return on capital | % | 19.7 | 16.0 | 20.3 | 18.4 | 9.5 | |
Exports to sales | % | 69.6 | 72.3 | 68.7 | 72.8 | 67.6 | |
Imports to sales | % | 37.1 | 29.7 | 26.9 | 24.2 | 25.6 | |
Exports (fob) | Rs m | 11,056 | 10,892 | 11,823 | 14,142 | 13,684 | |
Imports (cif) | Rs m | 5,893 | 4,476 | 4,623 | 4,698 | 5,184 | |
Fx inflow | Rs m | 11,056 | 10,892 | 11,823 | 14,142 | 13,684 | |
Fx outflow | Rs m | 5,893 | 4,476 | 4,623 | 4,698 | 5,184 | |
Net fx | Rs m | 5,163 | 6,416 | 7,200 | 9,444 | 8,500 |
HIKAL. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,856 | 2,849 | 2,290 | 2,937 | 3,153 | |
From Investments | Rs m | -1,246 | -1,638 | -1,562 | -2,844 | -2,923 | |
From Financial Activity | Rs m | -554 | -1,009 | -969 | -56 | -77 | |
Net Cashflow | Rs m | 56 | 203 | -240 | 38 | 153 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Jai Hiremath | COMP SEC: Rajasekhar Reddy | YEAR OF INC: 1988 | BSE CODE: 524735 | FV (Rs): 2 | DIV YIELD (%): 0.4 |
Read: HIKAL. 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare HIKAL. With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.